- Global Pharma News & Resources

Human Chorionic Gonadotropin (HCG) Market 2019 – Size, Share, Historical Analysis, Recent Trends, Future Scope and Potential of Industry by 2026

Human chorionic gonadotropin hormone (HCG) or also called pregnancy, which is produced by cells formed in the placenta that nourishes the egg after it has been fertilized and becomes attached to the uterine wall. The HCG is mainly used to stimulate ovulation in women under infertility treatment. It is also used among males mostly to increase the sperm count and in young boys, due to pituitary gland disorders and other diseases, due to which the testicles of the young males does not drop down naturally into the scrotum.     The HCG is usually administered as an injection under the skin into a muscle. Generally, HCG is administered under a gynecologist’s guidance or pharmacist’s guidance. The HCG levels can be determined with the help of urine or blood test. Result of specific test helps in the determining accurate measurement of the levels. These tests are mostly used to identify and confirm pregnancy or as a screening test to determine birth defects.

Request Sample Copy of the Business Report:

Market Dynamics- Drivers

Growing occurrence of infertility are expected to drive growth of the global human Chorionic gonadotropin (HCG) market

Increasing incidence of infertility cases is expected to drive growth of the global human Chorionic gonadotropin (HCG) market during the forecast period. According to Centers of Disease Control and Prevention (CDC) in 2016, around 7.3 million women aged 15 – 44 years have used infertility services. Moreover, 6.7% of the married women aged 15 – 44 years were reported infertile. According to Azura Vascular Care, around 17% of the couples in the U.S. deal with infertility, out of which 30% cases are a result of male infertility. Thus, these numbers suggests significant demand for infertility treatments, such as HCG in order for females to conceive a child. According to a statistical survey conducted by HealthGrove, pituitary gland disorders resulted into the death of around 205 people in 2015, out of which highest percentage belonged to white men. Pituitary disorders resulting into significant mortality rate are propelling the demand for human chorionic gonadotropin hormone. Moreover, various other factors such as endometriosis, hormonal imbalance, polycystic ovary syndrome, and others are expected to propel the growth of global HCG market. For instance, according to Frisco Institute of Reproductive Medicine, around 10% of women of reproductive age in the U.S. suffer from polycystic ovary syndrome. Thus, these factors are expected to drive growth of the global human chorionic gonadotropin (HCG) market over the forecast period.

Quick Buy – Human Chorionic Gonadotropin (HCG) Market Research Report:

Market Dynamics- Restraints

Easy of alternative treatment options available for infertility is expected to restrain growth of the market in the near future.

Market Taxonomy:

The global human chorionic gonadotropin by Coherent Market Insights is segmented on the basis of Technology, Therapeutic area, and end user.

On the basis of technology, the global human chorionic gonadotropin is segmented as:

  • Natural Source Extraction
  • Recombinant DNA Technology

On the basis of therapeutic area, the global human chorionic gonadotropin market is segmented as:

  • Female infertility treatment
  • Oligospermic Treatment
  • Cryptorchidism Treatment
  • Others

On the basis of end user, the global human chorionic gonadotropin market is segmented as:

  • Fertility Centers
  • Research Institutes
  • Others

Note: *The Download PDF brochure only consist of Table of Content, Research Framework, and Research Methodology.

Request PDF Research Report Brochure @

Regional Insights

North America to hold dominant position in the global human chorionic gonadotropin (HCG) market, owing to rising frequency of infertility cases

On the basis of geography, the global human chorionic gonadotropin (HCG) market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Among regions, North America accounted for the largest share in the market and is expected to continue its dominance during the forecast period. This is owing to rising number of infertility cases coupled with hormonal dysfunction among young males and females as a result of changing lifestyle. According to Mayo Clinic, around 25% of women fertility problems in the U.S. are a result of ovulation issues that are mostly caused due to dysfunction of human chorionic gonadotropin (HCG) hormone. Thus, the rapidly increasing cases of infertility are expected to surge the North America global human chorionic gonadotropin (HCG) market. Moreover, Asia Pacific is expected to be the fasting growing region, owing to economic developments facilitating technological advancements in healthcare sectors as well as emerging local players in the market.

Competitive Landscape

Major companies operating the global human chorionic gonadotropin (HCG) market include Merck & Co., Inc., EMD Sereno, Inc., Fresenius Kabi, Bristol Myers Squibb Company, Ferring BV, and Kamia Biomedical Company. Acris Antibodies developed a human chorionic gonadotropin hormone by recombinant DNA technology that helps to prevent the disintegration of the corpus luteum of the ovary thereby, maintaining levels of progesterone production for healthy pregnancy in females.

To understand Research Methodology, please click

Table of Content

Global Human Chorionic Gonadotropin (HCG) Market Research Report
Section 1: Global Human Chorionic Gonadotropin (HCG) Industry Overview
Section 2: Global Economic Impact on Human Chorionic Gonadotropin (HCG) Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Human Chorionic Gonadotropin (HCG) Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Human Chorionic Gonadotropin (HCG) Market Forecast

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 12-Mar-2021